2596 related articles for article (PubMed ID: 29094161)
21. Mendelian randomization study for the roles of IL-18 and IL-1 receptor antagonist in the development of inflammatory bowel disease.
Mi J; Liu Z; Pei S; Wu X; Zhao N; Jiang L; Zhang Z; Bai X
Int Immunopharmacol; 2022 Sep; 110():109020. PubMed ID: 35843146
[TBL] [Abstract][Full Text] [Related]
22. High-sensitivity C-reactive protein, low-grade systemic inflammation and type 2 diabetes mellitus: A two-sample Mendelian randomization study.
Noordam R; Oudt CH; Bos MM; Smit RAJ; van Heemst D
Nutr Metab Cardiovasc Dis; 2018 Aug; 28(8):795-802. PubMed ID: 29753585
[TBL] [Abstract][Full Text] [Related]
23. Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysis.
Yarmolinsky J; Robinson JW; Mariosa D; Karhunen V; Huang J; Dimou N; Murphy N; Burrows K; Bouras E; Smith-Byrne K; Lewis SJ; Galesloot TE; Kiemeney LA; Vermeulen S; Martin P; Albanes D; Hou L; Newcomb PA; White E; Wolk A; Wu AH; Le Marchand L; Phipps AI; Buchanan DD; ; ; Zhao SS; Gill D; Chanock SJ; Purdue MP; Davey Smith G; Brennan P; Herzig KH; Järvelin MR; Amos CI; Hung RJ; Dehghan A; Johansson M; Gunter MJ; Tsilidis KK; Martin RM
EBioMedicine; 2024 Feb; 100():104991. PubMed ID: 38301482
[TBL] [Abstract][Full Text] [Related]
24. Mendelian Randomization Study on Causal Association of IL-6With Breast Cancer.
Zhang M; Ma N; Wang R
Clin Breast Cancer; 2023 Jun; 23(4):e182-e188. PubMed ID: 36813657
[TBL] [Abstract][Full Text] [Related]
25. C-reactive protein levels and body mass index: elucidating direction of causation through reciprocal Mendelian randomization.
Timpson NJ; Nordestgaard BG; Harbord RM; Zacho J; Frayling TM; Tybjærg-Hansen A; Smith GD
Int J Obes (Lond); 2011 Feb; 35(2):300-8. PubMed ID: 20714329
[TBL] [Abstract][Full Text] [Related]
26. Association Between Population Density and Genetic Risk for Schizophrenia.
Colodro-Conde L; Couvy-Duchesne B; Whitfield JB; Streit F; Gordon S; Kemper KE; Yengo L; Zheng Z; Trzaskowski M; de Zeeuw EL; Nivard MG; Das M; Neale RE; MacGregor S; Olsen CM; Whiteman DC; Boomsma DI; Yang J; Rietschel M; McGrath JJ; Medland SE; Martin NG
JAMA Psychiatry; 2018 Sep; 75(9):901-910. PubMed ID: 29936532
[TBL] [Abstract][Full Text] [Related]
27. Associations of immunological proteins/traits with schizophrenia, major depression and bipolar disorder: A bi-directional two-sample mendelian randomization study.
Perry BI; Upthegrove R; Kappelmann N; Jones PB; Burgess S; Khandaker GM
Brain Behav Immun; 2021 Oct; 97():176-185. PubMed ID: 34280516
[TBL] [Abstract][Full Text] [Related]
28. Cardiometabolic effects of genetic upregulation of the interleukin 1 receptor antagonist: a Mendelian randomisation analysis.
Interleukin 1 Genetics Consortium
Lancet Diabetes Endocrinol; 2015 Apr; 3(4):243-53. PubMed ID: 25726324
[TBL] [Abstract][Full Text] [Related]
29. Genetic Evidence on the Association of Interleukin (IL)-1-Mediated Chronic Inflammation with Airflow Obstruction: A Mendelian Randomization Study.
Yang Z; Schooling CM; Kwok MK
COPD; 2021 Aug; 18(4):432-442. PubMed ID: 34348529
[TBL] [Abstract][Full Text] [Related]
30. Leveraging genetic data to investigate the effects of interleukin-6 receptor signalling on levels of 40 circulating cytokines.
Rahman RP; McEwan L; Ryan DK; Gill D
Br J Clin Pharmacol; 2022 Mar; 88(3):1373-1378. PubMed ID: 34506050
[TBL] [Abstract][Full Text] [Related]
31. Associations of genetically determined iron status across the phenome: A mendelian randomization study.
Gill D; Benyamin B; Moore LSP; Monori G; Zhou A; Koskeridis F; Evangelou E; Laffan M; Walker AP; Tsilidis KK; Dehghan A; Elliott P; Hyppönen E; Tzoulaki I
PLoS Med; 2019 Jun; 16(6):e1002833. PubMed ID: 31220083
[TBL] [Abstract][Full Text] [Related]
32. Elevated C-reactive protein associated with late- and very-late-onset schizophrenia in the general population: a prospective study.
Wium-Andersen MK; Ørsted DD; Nordestgaard BG
Schizophr Bull; 2014 Sep; 40(5):1117-27. PubMed ID: 23996346
[TBL] [Abstract][Full Text] [Related]
33. Association of plasma IL-6 and soluble IL-6 receptor levels with the Asp358Ala polymorphism of the IL-6 receptor gene in schizophrenic patients.
Sasayama D; Wakabayashi C; Hori H; Teraishi T; Hattori K; Ota M; Ishikawa M; Arima K; Higuchi T; Amano N; Kunugi H
J Psychiatr Res; 2011 Nov; 45(11):1439-44. PubMed ID: 21700295
[TBL] [Abstract][Full Text] [Related]
34. C-reactive protein and risk of Alzheimer's disease.
Zhang Z; Wang M; Liu X
Neurobiol Aging; 2022 Jan; 109():259-263. PubMed ID: 34538509
[TBL] [Abstract][Full Text] [Related]
35. Genetic correlation and causal associations between circulating C-reactive protein levels and lung cancer risk.
Shi J; Wen W; Long J; Xue H; Yang Y; Tao R; Pan W; Shu XO; Cai Q
Cancer Causes Control; 2024 Jun; 35(6):897-906. PubMed ID: 38332239
[TBL] [Abstract][Full Text] [Related]
36. Sensitivity Analyses for Robust Causal Inference from Mendelian Randomization Analyses with Multiple Genetic Variants.
Burgess S; Bowden J; Fall T; Ingelsson E; Thompson SG
Epidemiology; 2017 Jan; 28(1):30-42. PubMed ID: 27749700
[TBL] [Abstract][Full Text] [Related]
37. Genetic estimates of correlation and causality between blood-based biomarkers and psychiatric disorders.
Reay WR; Kiltschewskij DJ; Geaghan MP; Atkins JR; Carr VJ; Green MJ; Cairns MJ
Sci Adv; 2022 Apr; 8(14):eabj8969. PubMed ID: 35385317
[TBL] [Abstract][Full Text] [Related]
38. Investigating evidence for a causal association between inflammation and self-harm: A multivariable Mendelian Randomisation study.
Russell AE; Ford T; Gunnell D; Heron J; Joinson C; Moran P; Relton C; Suderman M; Hemani G; Mars B
Brain Behav Immun; 2020 Oct; 89():43-50. PubMed ID: 32473944
[TBL] [Abstract][Full Text] [Related]
39. Is there a shared genetic basis and causal relationship between polycystic ovary syndrome and psychiatric disorders: evidence from a comprehensive genetic analysis.
Jiang X; Deng Q; Stener-Victorin E
Hum Reprod; 2021 Jul; 36(8):2382-2391. PubMed ID: 34051085
[TBL] [Abstract][Full Text] [Related]
40. Downregulation of interleukin 6 signaling might reduce the risk of periodontitis: a drug target Mendelian randomization study.
Nolde M; Alayash Z; Reckelkamm SL; Kocher T; Ehmke B; Holtfreter B; Baurecht H; Georgakis MK; Baumeister SE
Front Immunol; 2023; 14():1160148. PubMed ID: 37342352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
